Tc-99m Sestamibi Uptake by Parathyroid Carcinoma
Dwight M. Achong, Elizabeth Oates
Abstract
Dwight M. Achong, Elizabeth Oates
Abstract
Tc-99m sestamibi (MIBI) is increasingly used for the preoperative localization of parathyroid adenoma. As experience is gained with this radiopharmaceutical, instances of uptake by non-adenomas will be encountered. A case of focal Tc-99m MIBI uptake by parathyroid carcinoma mimicking parathyroid adenoma is presented.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Tc-99m sestamibi (MIBI) is increasingly used for the preoperative localization of parathyroid adenoma. As experience is gained with this radiopharmaceutical, instances of uptake by non-adenomas will be encountered. A case of focal Tc-99m MIBI uptake by parathyroid carcinoma mimicking parathyroid adenoma is presented.
Key concepts: Medicine, Parathyroid carcinoma, Parathyroid adenoma, Technetium Tc 99m Sestamibi, Parathyroid neoplasm, Adenoma, Carcinoma, Radiology